Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × matuzumab × Clear all

NCT00073541 2017-01-20

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms